On August 26, Dycom declined 5.03% in regular trading, trading at $326.90 per share, with turnover of approximately $79.92 million.

The decline came despite the company reporting record fiscal Q2 results that broadly exceeded expectations. Dycom posted adjusted EPS of $5.29, beating the consensus estimate of $4.72 by 12%, while contract revenue rose to $2.01 billion versus the $1.98 billion expected. However, the company only raised its full-year fiscal 2027 contract revenue guidance to $7.48 billion–$7.66 billion from the prior $7.38 billion–$7.65 billion, a modest adjustment that contrasted sharply with the dramatic Q1 revision from $6.85 billion–$7.15 billion to $7.38 billion–$7.65 billion, which had driven a single-day surge of over 28%.

Additionally, Dycom announced board approval of a new $150 million stock buyback plan replacing a prior program with approximately $83.9 million remaining, but this failed to offset selling pressure as the market appeared to have priced in a more aggressive outlook upgrade.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)